This ADRC is an integrated unit of Washington University that coordinates and supports the work of established investigators and teachers from diverse backgrounds. Mechanisms are provided for the support of programs and projects with a focus on both clinical and basic science research, and the development of improved training of professionals within the University and outreach programs for health care professionals and the public in the regional community. The clinical theme of the research component in this application is the identification and characterization of mild and very mild dementia of the Alzheimer type (DAT) in comparison with healthy aging.The basic science theme is the characterization of neurobiological principles and mechanisms relevant to aging of the nervous system and neuronal dysfunction and/or death in Alzheimer's disease (AD). Five cores (Biostatistics, Clinical, Psychometric, Neuropathology/Tissue Resource, Administration) will support five projects and five pilots. The topics of the projects include: 1) ApoE clearance receptor in CNS; 2) cellular prion proteins; 3) gene expression and neuronal vulnerability in neurodegenerative disease; 4) molecular genetics of dementia; and 5) processing speed, working memory and fluid cognitive abilities in DAT. The pilots study: 1) structure of the A-beta-protein; 2) AD and fibroblast bradykinin receptor modulation; 3) an AMPA receptor modulatory site; 4) protein fatty acylation in neuronal growth and remodeling; and 5) cognitive deficits and speech perception in DAT. A Training and Information-Transfer core supports our educational activities. Two Satellite components reach out to African Americans in our community and to the underserved rural areas of our region. This ADRC also interacts with and supports other investigators at this University, funded through other mechanisms, in order to focus attention on issues relevant to aging, AD and other dementias. Finally, the ADRC interacts with other Centers and the Alzheimer's Association to coordinate our efforts.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005681-12
Application #
2049265
Study Section
Special Emphasis Panel (ZAG1-DAG-4 (52))
Project Start
1985-09-30
Project End
2000-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
12
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Washington University
Department
Neurology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Vlassenko, Andrei G; Gordon, Brian A; Goyal, Manu S et al. (2018) Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease. Neurobiol Aging 67:95-98
Javaherian, Kavon; Newman, Brianne M; Weng, Hua et al. (2018) Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer Disease. Alzheimer Dis Assoc Disord :
Wildburger, Norelle C; Gyngard, Frank; Guillermier, Christelle et al. (2018) Amyloid-? Plaques in Clinical Alzheimer's Disease Brain Incorporate Stable Isotope Tracer In Vivo and Exhibit Nanoscale Heterogeneity. Front Neurol 9:169
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Qiu, Shangran; Chang, Gary H; Panagia, Marcello et al. (2018) Fusion of deep learning models of MRI scans, Mini-Mental State Examination, and logical memory test enhances diagnosis of mild cognitive impairment. Alzheimers Dement (Amst) 10:737-749
Pehlivanova, Marieta; Wolf, Daniel H; Sotiras, Aristeidis et al. (2018) Diminished Cortical Thickness is Associated with Impulsive Choice in Adolescence. J Neurosci :
Gordon, Brian A; Blazey, Tyler M; Su, Yi et al. (2018) Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. Lancet Neurol 17:241-250
Jansen, Willemijn J; Ossenkoppele, Rik; Tijms, Betty M et al. (2018) Association of Cerebral Amyloid-? Aggregation With Cognitive Functioning in Persons Without Dementia. JAMA Psychiatry 75:84-95
Allison, Samantha; Babulal, Ganesh M; Stout, Sarah H et al. (2018) Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation Abilities. Alzheimer Dis Assoc Disord 32:101-106
Stout, Sarah H; Babulal, Ganesh M; Ma, Chunyu et al. (2018) Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers. Alzheimers Dement 14:610-616

Showing the most recent 10 out of 952 publications